Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biolargo Inc BLGO

Chemicals Specialty Chemicals
BioLargo, Inc. is a cleantech and life sciences innovator and engineering services solution provider. The Company operates through six segments: ONM Environmental, Clyra Medical Technologies (Clyra Medical), BioLargo Engineering (BLEST), BioLargo Canada, Inc. (Canada), BioLargo Energy Technologies, Inc. (BETI), and BioLargo Equipment Solutions & Technologies, Inc. (BEST). ONM Environmental... see more

Recent & Breaking News (OTCQX:BLGO)

BioLargo Engineering Awarded EPA Grant to Develop Methods to Remove Toxic Contaminants from Water

Accesswire April 30, 2019

BioLargo's Odor-No-More Enters Cannabis and Hemp Odor Control Industry with Experienced Distribution Partner Through White Label Agreement

Accesswire April 15, 2019

BioLargo Letter to Stockholders Highlights the Impact of its Innovative Technology Assets

Accesswire April 1, 2019

BioLargo Supplies Odor and VOC Control Solution to Cannabis Industry: An Uptick Newswire Stock Day Podcast Interview

Accesswire March 11, 2019

Uptick Newswire Hosts BioLargo, Inc.’s CEO to Discuss the Company’s Outlook for 2019 and Share its 2018 Milestones

GlobeNewswire January 24, 2019

BioLargo Letter to Stockholders on Revenue Records in 2018 and Forecasted Positive Cash Flow in 2019

GlobeNewswire January 23, 2019

BioLargo’s subsidiary Clyra Medical secures over $1 million in direct investments to finalize the acquisition of the breakthrough stem cell therapy technology SkinDisc

GlobeNewswire December 19, 2018

BioLargo to Present at the 11th Annual LD Micro Main Event

Accesswire November 27, 2018

BioLargo's Advanced Oxidation System (AOS) Test Data Shows Breakthrough to Treat and Reduce the Toxicity of Micropollutants Associated with Municipal Wastewater

Accesswire November 21, 2018

BioLargo Tops $1M in Annual Revenues for First Time

Accesswire November 19, 2018

BioLargo Reports Record Results

Accesswire November 15, 2018

BioLargo, Inc.’s CEO Discusses Business Milestones and FDA Progress with Uptick Newswire’s Stock Day Podcast

GlobeNewswire November 5, 2018

BioLargo Letter to Stockholders Details Company’s Recent Milestones and Successes

GlobeNewswire October 31, 2018

BioLargo Closes Bridge Financing with TRITON FUNDS LP, the Largest Student-Run Investment Fund in the Nation

GlobeNewswire October 22, 2018

BioLargo acquires breakthrough stem cell therapy technology to expand medical product portfolio

GlobeNewswire October 2, 2018

BioLargo CEO Dennis Calvert Reports Breakthrough Commercial Success

GlobeNewswire September 25, 2018

BioLargo Announces Participation at the 20th Annual Global Investment Conference in New York City September 4-6, 2018

GlobeNewswire September 4, 2018

BioLargo Announces Craft Brewery Pre-Commercial Pilot Study Project Funded by Innovative Conservation Program (ICP)

GlobeNewswire August 23, 2018

Dennis Calvert, CEO of BioLargo, Inc., Returns to Uptick Newswire’s Stock Day Podcast to Discuss the Company’s Record-Breaking Quarterly Results and a Progress Report on its March to its First Industry-Wide Adoption

GlobeNewswire August 16, 2018

BioLargo Achieves Record Product Sales and Revenues - Marching to First Industry-Wide Adoption

GlobeNewswire August 14, 2018